SNCA and Parkinson disease: The inability of dopamine replacement therapy to effectively treat vocalization deficits leads to the hypothesis that some aspects of the vocal deficits in PD are not a result of the hallmark pathology in the striatal dopaminergic system but instead result from alpha-synuclein pathology in specific extra-striatal vocal communication areas.